ANN:ASXAnsell Limited Analysis
Data as of 2026-03-15 - not real-time
A$29.75
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ansell Limited is trading at AUD 29.75, comfortably below its 20‑day (≈31.5), 50‑day (≈32.7) and 200‑day (≈33.1) simple moving averages, signaling a bearish price bias. The RSI sits at 33, hinting at oversold conditions, while the MACD line remains under the signal line, reinforcing the downside momentum. Volume is on a decreasing trend and volatility is elevated at roughly 31% over the past month, suggesting heightened short‑term risk.
Fundamentally, the stock trades at a forward PE of 13.3 versus a trailing PE of 22.7, well under the industry average PE of 26.2, and offers a 2.7% dividend yield with a payout ratio near 53%, which appears sustainable given positive operating cash flow. Debt levels are moderate (debt‑to‑equity ~42%) and the beta of 0.48 points to lower market sensitivity, but the high max drawdown of 21% and a support zone around 29.0 indicate limited upside before encountering resistance near 33.7.
Fundamentally, the stock trades at a forward PE of 13.3 versus a trailing PE of 22.7, well under the industry average PE of 26.2, and offers a 2.7% dividend yield with a payout ratio near 53%, which appears sustainable given positive operating cash flow. Debt levels are moderate (debt‑to‑equity ~42%) and the beta of 0.48 points to lower market sensitivity, but the high max drawdown of 21% and a support zone around 29.0 indicate limited upside before encountering resistance near 33.7.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below all key moving averages
- Bearish MACD and decreasing volume
- Proximity to near‑term support at 29.0
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of 13.3 indicating earnings growth
- Undervalued relative to industry PE
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable cash flow and dividend record
- Global exposure across healthcare and industrial segments
- Moderate debt level and low beta reducing market volatility
Key Metrics & Analysis
Financial Health
Revenue Growth0.70%
Profit Margin6.74%
P/E Ratio22.7
ROE6.96%
ROA5.71%
Debt/Equity41.63
P/B Ratio1.5
Op. Cash FlowA$277.5M
Free Cash FlowA$114.5M
Industry P/E26.2
Technical Analysis
TrendBearish
RSI33.1
SupportA$29.01
ResistanceA$33.74
MA 20A$31.49
MA 50A$32.69
MA 200A$33.05
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueA$7.07
Target PriceA$36.71
Upside/Downside23.41%
GradeUndervalued
TypeBlend
Dividend Yield2.70%
Risk Assessment
Beta0.48
Volatility30.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.